Research & Development
19 July 2019 - - US-based biopharmaceutical company Nexien BioPharma, Inc. (OTCQB: NXEN) has been granted Patent No. 238946 for "Use of Cannabinoids and Terpenes for Treatment of Organophosphate ...
19 July 2019 - - The US Food and Drug Administration granted rare pediatric disease designation to LM-030, an investigational therapy licensed from Swiss drugmaker Novartis and ready to enter into piv...
19 July 2019 - Precision therapy company Blueprint Medicines Corporation (NASDAQ:BPMC) on Thursday reported the European Medicines Agency's (EMA) validation of its Marketing Authorization Applica...
19 July 2019 - Pharmaceutical companies Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) on Thursday jointly reported the launch of the therapeutic biosimilars MVASI and KANJINTITM in the US oncology m...
19 July 2019 - The US Food and Drug Administration (FDA) has granted approval to United States-based Merck for its Recarbrio (imipenem, cilastatin and relebactam) intended to treat adults with complic...
19 July 2019 - Swedish Orphan Biovitrum AB (Sobi) (STO:SOBI), a specialised international biopharmaceutical company, announced on Thursday that it has completed the acquisition of the newly establishe...
Related Headlines